Japanese Encephalitis Market Global Industry Analysis and Forecast Till 2020

Japanese encephalitis is a mosquito-borne viral infection mostly found in the rural parts of the Asia. Encephalitis According to World Health Organization, intensification and expansion of irrigated rice production system in South-East Asia over past 20 years is primarily responsible for escalating the disease burden by Japanese encephalitis. The disease is caused by flavivirus and affects approximately 68,000 people annually in Asia.Astonishingly there is no permanent cure to the fetal disease and about 20-30% of patient usually dies within a short span of time from the onset of disease. Moreover approximately 50% of the survived patient population develops permanent brain damage. The disease can be broadly classified into three prominent categories: prodromal febrile stage followed by acute encephalitic stage marked by CNS involvement. The last stage is either marked by either recovery or persistence of symptoms with permanent neural damage.

Obtain Report Details @ http://www.transparencymarketresearch.com/japanese-encephalitis-market.html

Apart from paddy fields Japanese encephalitis is also predominant in areas where pigs are here pigs are intensively raised and is passed to mosquitoes that bite the infected pigs. Major outbreaks of Japanese encephalitis occurs usually in every 5-10 years

Symptoms of the Japanese encephalitis include mild fever, prolonged headache, neck stiffness, coma, seizures, spastic paralysis, drowsiness, dilated pupil, disorientation. Additionally onset of mental issues such as hallucinations, tremors and confusion are other common symptoms predominant among patients suffering from Japanese encephalitis. According to Centers for Disease Control and Prevention Inactivated Vero cell culture–derived Japanese encephalitis vaccine manufactured as IXIARO is the only licensed and available in the United States. In May 2013, FDA licensed IXIARO for use in children 2 months through 16 years of age. Vaccines such as SA14-14-2, IC51 marketed in Australia and New Zealand as JESPECT and ChimeriVax-JE marketed as IMOJEV are other very promising vaccines which are likely to escalate the overall market for Japanese encephalitis. Countries that had major epidemic in past include china, Republic of Korea, Japan, Taiwan and Thailand. Countries such as periodic Vietnam, Cambodia, Myanmar, India, Nepal, and Malaysia do have epidemics but instance are very rare as compared to the major epidemic countries. side effects of Japanese encephalitis vaccine include: fever, muscle pain, light headedness, stomach upset, seizures and skin rashes.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3766

Some of the major restraints to the growth of the market include high cost of the vaccines which is limiting the sales of the vaccines due to poverty and lack of appropriate healthcare infrastructure. An inexpensive live-attenuated vaccine is used in China, but is not available elsewhere. As preventive measure vaccination against Japanese encephalitis is compulsory for foreign travelers visiting to regions with high prevalence of infection. Though infection to travelers It is estimated that less than one in a million travelers develop Japanese encephalitis in any given year.

Geographically the market for Japanese encephalitis is majorly contributed by the Asia-pacific followed by the Rest of the World market pertaining to high prevalence rate and sales of vaccines. Lack of appropriate stock of preventive vaccine in the United States is major restraints to the growth of the market. Travelers are major contributors in spreading disease in European and America region. Key manufacturers for Japanese encephalitis market include Chengdu Institute of Biological Products Co., Ltd, Wuhan Institute of Biological Products Co., Ltd, Lanzhou Institute of Biological Products Co., Ltd, Intercell Biomedical Ltd., Novartis International AG, Sanofi Pasteur and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.